Market Cap 135.00M
Revenue (ttm) 10.22M
Net Income (ttm) -20.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -202.25%
Debt to Equity Ratio 0.00
Volume 148,800
Avg Vol 71,766
Day's Range N/A - N/A
Shares Out 21.77M
Stochastic %K 98%
Beta 2.51
Analysts Sell
Price Target $18.00

Company Profile

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatit...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 564 9244
Address:
750 West Pender Street, Suite 1200, Vancouver, Canada
SnowFlurry
SnowFlurry Apr. 7 at 7:06 PM
0 · Reply
SocioCobb
SocioCobb Apr. 7 at 3:14 PM
$ACOG watching this closely. Sitting at a critical resistance/support level. Close here or higher wpuld be bullish for continuing gains. S4 Open matket about 8 mos ago 20% higher- hmmmm
0 · Reply
NasdaqPulse
NasdaqPulse Apr. 3 at 5:18 PM
Investor AI Fund early signals are firing ⚡ 👉Click to view @NasdaqPulse for timely updates amid the volatility. Desk 1 (Insider Intelligence) is already spotting strength with $ACOG +18.6% and $TGEN +14.1% leading the charge — early alpha showing up fast. But Desk 2 (Options Flow Hunter) is waving caution flags as $TTD slips -3.1%, hinting at weakening momentum under the surface. This is where it gets interesting: signal confluence is kicking in, forcing systematic rebalancing across desks. Strength gets rotated into, weakness gets cut — no emotions, just data. Smart money isn’t guessing… it’s adapting in real time. All eyes on the system as we track positioning ahead of the April launch
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 2 at 7:35 AM
$ACOG https://www.businesswire.com/news/home/20260401736131/en/Alpha-Cognition-Receives-Issued-U.S.-Patent-for-ALPHA-1062-for-Treatment-of-Traumatic-Brain-Injury
0 · Reply
focafoca99
focafoca99 Apr. 1 at 9:51 PM
$ACOG picked up a new U.S. patent around ALPHA-1062 for traumatic brain injury, which helps extend the IP story beyond Alzheimer's.
0 · Reply
jumptime
jumptime Apr. 1 at 9:33 PM
$ACOG BRIEF-Alpha Cognition Receives Issued U.S. Patent For Alpha-1062 For Treatment Of Traumatic Brain Injury
0 · Reply
LewisDaKat
LewisDaKat Apr. 1 at 7:00 PM
$ACOG Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425 https://marketwirenews.com/stock/acog/news/stonegate-capital-partners-updates-coverage-on-alpha-5505211532967784.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat Apr. 1 at 6:30 PM
$ACOG Alpha Cognition (ACOG) Q4 2025 Earnings Transcript https://marketwirenews.com/stock/acog/news/alpha-cognition-acog-q4-2025-earnings-transcript-6348690691221924.html?utm_source=stocktwits
0 · Reply
newsfile_corp
newsfile_corp Apr. 1 at 1:52 PM
https://nfne.ws/290861 $ACOG @reportablenews #NASDAQ #Investing
0 · Reply
Bioinvester001
Bioinvester001 Mar. 31 at 5:02 PM
$ACOG Sleep disorders is the new big pharma focus. Acog addresses this with it's ALZ drug, and look for more interest in the company.
0 · Reply
Latest News on ACOG
Alpha Cognition to Present Clinical Data at ASCP Annual Meeting

Oct 6, 2025, 8:30 AM EDT - 6 months ago

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting


CSE Bulletin: Delist - Alpha Cognition Inc. (ACOG)

Dec 16, 2024, 11:51 AM EST - 1 year ago

CSE Bulletin: Delist - Alpha Cognition Inc. (ACOG)


Alpha Cognition Announces Voluntary Delisting from CSE

Dec 12, 2024, 6:41 PM EST - 1 year ago

Alpha Cognition Announces Voluntary Delisting from CSE


SnowFlurry
SnowFlurry Apr. 7 at 7:06 PM
0 · Reply
SocioCobb
SocioCobb Apr. 7 at 3:14 PM
$ACOG watching this closely. Sitting at a critical resistance/support level. Close here or higher wpuld be bullish for continuing gains. S4 Open matket about 8 mos ago 20% higher- hmmmm
0 · Reply
NasdaqPulse
NasdaqPulse Apr. 3 at 5:18 PM
Investor AI Fund early signals are firing ⚡ 👉Click to view @NasdaqPulse for timely updates amid the volatility. Desk 1 (Insider Intelligence) is already spotting strength with $ACOG +18.6% and $TGEN +14.1% leading the charge — early alpha showing up fast. But Desk 2 (Options Flow Hunter) is waving caution flags as $TTD slips -3.1%, hinting at weakening momentum under the surface. This is where it gets interesting: signal confluence is kicking in, forcing systematic rebalancing across desks. Strength gets rotated into, weakness gets cut — no emotions, just data. Smart money isn’t guessing… it’s adapting in real time. All eyes on the system as we track positioning ahead of the April launch
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 2 at 7:35 AM
$ACOG https://www.businesswire.com/news/home/20260401736131/en/Alpha-Cognition-Receives-Issued-U.S.-Patent-for-ALPHA-1062-for-Treatment-of-Traumatic-Brain-Injury
0 · Reply
focafoca99
focafoca99 Apr. 1 at 9:51 PM
$ACOG picked up a new U.S. patent around ALPHA-1062 for traumatic brain injury, which helps extend the IP story beyond Alzheimer's.
0 · Reply
jumptime
jumptime Apr. 1 at 9:33 PM
$ACOG BRIEF-Alpha Cognition Receives Issued U.S. Patent For Alpha-1062 For Treatment Of Traumatic Brain Injury
0 · Reply
LewisDaKat
LewisDaKat Apr. 1 at 7:00 PM
$ACOG Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425 https://marketwirenews.com/stock/acog/news/stonegate-capital-partners-updates-coverage-on-alpha-5505211532967784.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat Apr. 1 at 6:30 PM
$ACOG Alpha Cognition (ACOG) Q4 2025 Earnings Transcript https://marketwirenews.com/stock/acog/news/alpha-cognition-acog-q4-2025-earnings-transcript-6348690691221924.html?utm_source=stocktwits
0 · Reply
newsfile_corp
newsfile_corp Apr. 1 at 1:52 PM
https://nfne.ws/290861 $ACOG @reportablenews #NASDAQ #Investing
0 · Reply
Bioinvester001
Bioinvester001 Mar. 31 at 5:02 PM
$ACOG Sleep disorders is the new big pharma focus. Acog addresses this with it's ALZ drug, and look for more interest in the company.
0 · Reply
jumptime
jumptime Mar. 31 at 3:04 PM
$ACOG Volume...
0 · Reply
rombrento
rombrento Mar. 30 at 9:47 PM
0 · Reply
theflynews
theflynews Mar. 30 at 4:21 PM
Biotech Alert: Searches spiking for these stocks today - $ACOG - https://thefly.com/ACOG
0 · Reply
Fingerlickengood
Fingerlickengood Mar. 30 at 3:18 PM
$ACOG https://www.investing.com/news/sec-filings/alpha-cognition-enters-75-million-atthemarket-offering-agreement-with-wainwright-93CH-4207800
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 26 at 9:21 PM
$ACOG Q4 '25 Earnings Results & Recap Alpha Cognition targets operating profitability in 2027 and expects a cash runway of approximately two years at forecasted operating levels. Alpha Cognition also anticipates two product approvals ex-US via its partner.
0 · Reply
JackCampbell
JackCampbell Mar. 26 at 9:20 PM
$ACOG a second big payer (of 4 big ones) pbm was signed by end of last year. Two approvals in asia expected in 2026 which will trigger a milestone payment.
0 · Reply
endrow
endrow Mar. 26 at 8:40 PM
$ACOG Fourth quarter bottles dispensed increased 62% quarter-over-quarter to 4,941, with December representing the strongest month since launch. Not YoY, but quarter-over-quarter 62% increase. Not bad.
1 · Reply
jumptime
jumptime Mar. 26 at 8:12 PM
$ACOG Whatever...
0 · Reply
Bioinvester001
Bioinvester001 Mar. 16 at 2:38 PM
$ACOG Earnings could show a big increase in payer accounts. Could be this stock is finally ready to move up.
0 · Reply
jumptime
jumptime Mar. 12 at 6:03 PM
$ACOG When....?
0 · Reply
JackCampbell
JackCampbell Mar. 11 at 9:55 AM
$ACOG FYI: Institutional Shares (Long) 9,909,100/ +45.58% (ex 13D/G) - change of +4.33MM shares +77.53% MRQ Institutional Value (Long) $ 64,397 USD ($1000)
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Mar. 10 at 7:50 PM
$ACOG https://www.businesswire.com/news/home/20260310594648/en/Alpha-Cognition-to-Present-New-Clinical-on-ZUNVEYL-Benzgalantamine-at-Multiple-Upcoming-Alzheimers-Association-International-Conferences
0 · Reply